Avanos Medical, Inc.
AVNS
$13.11
-$0.01-0.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 99.67% | -132.56% | -4,366.67% | 833.33% | -3,883.81% |
| Total Depreciation and Amortization | -10.81% | -19.66% | -11.50% | -15.79% | -3.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.23% | 169.70% | 1,156.25% | 17.14% | 11,838.24% |
| Change in Net Operating Assets | -45.56% | -178.38% | -181.93% | 124.55% | 862.71% |
| Cash from Operations | -51.30% | -39.13% | -75.54% | 421.25% | 355.91% |
| Capital Expenditure | -43.75% | -133.33% | -86.44% | -63.41% | 18.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -102.36% |
| Other Investing Activities | 71.43% | 98.20% | -204.76% | -- | -- |
| Cash from Investing | 10.53% | -162.50% | -123.73% | -355.00% | -109.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 91.21% | 82.58% | -60.00% | -135.34% | 71.74% |
| Issuance of Common Stock | -- | -50.00% | -- | -20.00% | -- |
| Repurchase of Common Stock | -200.00% | 100.00% | 77.14% | 75.82% | 98.44% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 90.15% | 87.50% | 36.00% | -4,057.14% | 76.11% |
| Foreign Exchange rate Adjustments | 114.29% | -116.67% | 680.00% | 250.00% | -362.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.21% | -518.75% | -140.85% | 10.08% | 196.39% |